Page last updated: 2024-08-26

1-methyl-1,2,3,4-tetrahydroisoquinoline and Drug Withdrawal Symptoms

1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with Drug Withdrawal Symptoms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antkiewicz-Michaluk, L; Filip, M; Michaluk, J; Przegaliński, E; Romańska, I; Vetulani, J1

Other Studies

1 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and Drug Withdrawal Symptoms

ArticleYear
An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:3

    Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Limbic System; Male; Neural Pathways; Neuroprotective Agents; Norepinephrine; Rats; Reward; Secondary Prevention; Self Administration; Serotonin; Substance Withdrawal Syndrome; Tetrahydroisoquinolines; Ventral Tegmental Area

2007